On October 21, 2026, the Supreme Court rejected the Trump administration’s request to restrict medical treatment and accommodations for transgender people in federal prisons. The decision allows a lower court order blocking the policy to remain in place while the legal challenge proceeds. The ruling is an important development in the ongoing debate over transgender rights, access to healthcare, and the federal government’s authority over incarcerated people.
The dispute began after President Donald Trump issued an executive order restricting federal funding for certain medical treatments for transgender people in government custody. In response, the Bureau of Prisons introduced a policy that would end hormone therapy and gender-affirming surgeries for incarcerated people with gender dysphoria. The policy also sought to restrict certain accommodations for transgender prisoners.
Gender dysphoria is the distress some people experience when their gender identity does not align with their sex assigned at birth. The administration argued that these gender-affirming treatments were not necessary and that restricting them was justified by security and administrative concerns within federal prisons.
However, the policy faced legal challenges from three transgender people incarcerated in federal prisons, including one transgender woman and two transgender men. Their attorneys argued that the new restrictions would force the end of treatments that the Bureau of Prisons had provided to people with gender dysphoria since 1992.
The policy could affect nearly 1,000 incarcerated people in federal custody. The lawsuit raises questions about whether the government can discontinue established medical treatments for incarcerated people and what constitutional protections apply to people in its custody.
A lower federal court blocked the administration from enforcing the policy. The Justice Department then appealed to the Supreme Court, asking the justices to pause that ruling and allow the restrictions to take effect while the case continued. On October 21, the Supreme Court rejected the emergency request in an unsigned order. Justices Samuel Alito and Clarence Thomas stated that they would have granted the request. The decision leaves the lower court’s order in place, preventing the administration from immediately enforcing the restrictions.
However, the Supreme Court’s decision does not resolve the underlying lawsuit or determine whether the administration’s policy is constitutional. The legal challenge will continue in the lower courts.
The case highlights the challenges transgender people face when seeking health care in settings where the government controls their medical decisions. Incarcerated people depend on prison authorities for access to doctors, medication, and other necessary services so when a policy restricts particular treatment, people in custody may have limited options for obtaining care independently.
Although the ruling does not end the case, it prevents the Trump administration from immediately implementing the restrictions while the legal proceedings continue. The outcome of the lawsuit will have important consequences for transgender people in federal prisons if the restrictions are placed and as the case moves forward, it shows the importance of questioning how government policies affect vulnerable populations and how government decisions apply to people whose freedom and access to healthcare are already limited.